Lung Ultrasound for the Detection of Radiologic Progression of Interstitial Lung Abnormalities in Patients With Rheumatoid Arthritis
Ультразвуковое исследование легких для выявления рентгенологического прогрессирования интерстициальных изменений в легких у пациентов с ревматоидным артритом
2026-04-03
SCID: 54.1/cfx366ye
Discuss with AI
B-linesinterstitial lung abnormalitieslung ultrasonographyradiologic progressionrheumatoid arthritis
Figures from the paper
Abstract (AI)
OBJECTIVE: Interstitial lung disease (ILD) is an important extra-articular manifestation of rheumatoid arthritis (RA) associated with high mortality and morbidity. Lung ultrasonography (LUS) has recently emerged as a possible screening tool. We assessed the role of LUS in monitoring radiologic progression and the development of new interstitial lung abnormalities (ILAs). METHODS: In this prospective pilot study, patients with RA underwent high-resolution computed tomography (HRCT), pulmonary function tests (PFTs), symptom assessment, and LUS at baseline and 12 to 18 months later. B-lines were quantified using a 72-zone protocol. Radiologic changes across longitudinal HRCTs were scored on a five-point Likert scale by blinded thoracic radiologists. Six multivariable logistic regression models were built to predict HRCT progression using combinations of LUS parameters, PFTs, symptoms, and clinical characteristics. RESULTS: Eighty-one patients completed the follow-up HRCT, and per-protocol LUS was performed in 95% (77/81). Radiologic progression was observed in 31% (25/81). An increase in B-lines was significantly associated with radiologic progression (P = 0.018), and a linear trend was confirmed (P = 0.026). In multivariable analysis, both baseline B-lines (P = 0.029) and the change in B-lines over time (P = 0.012) significantly predicted progression (area under the curve [AUC] 0.78, 95% confidence interval [CI] 0.64-0.92). When combining LUS and change in diffusing capacity for carbon monoxide (AUC 0.82, 95% CI 0.70-0.94), the model fit remained similar and outperformed symptom scores (AUC 0.58, 95% CI 0.40-0.75, P = 0.020) and PFTs (AUC 0.59, 95% CI 0.44-0.74, P = 0.022). CONCLUSION: LUS may be a useful, radiation-free tool to monitor and predict radiologic progression of ILAs in RA. These findings support further research into integrating LUS into longitudinal RA-ILD assessment, particularly as part of a multimodal approach.
Key Findings
1
Baseline B-lines and their longitudinal change independently predicted progression, achieving an AUC of 0.78 (95% CI 0.64–0.92).
2
Combining lung ultrasound with change in diffusing capacity for carbon monoxide yielded an AUC of 0.82, outperforming symptom scores and pulmonary function tests alone.
3
In this prospective pilot study, radiologic progression of interstitial lung abnormalities occurred in 31% of rheumatoid arthritis patients over 12–18 months.
4
Increasing lung ultrasound B-lines was significantly associated with radiologic progression, with a confirmed linear trend over time.
5
Lung ultrasound may provide a radiation-free method for longitudinal monitoring and prediction of interstitial lung abnormality progression in rheumatoid arthritis, although further validation is needed.
Research Object
Interstitial lung abnormalities in patients with rheumatoid arthritis
Research Subject
Radiologic progression and development of new interstitial lung abnormalities, and their prediction and monitoring using lung ultrasound
Publication Details
Publication Date
2026-04-03
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest